• N&PD Moderators: Skorpio | thegreenhand

Salvia splendens - ingredients and uses.

2006 - Clerodane Diterpenoids from Salvia splendens



Four new clerodane diterpenoids, salvisplendins A-D (1-4), have been isolated from an acetone extract of the flowers
of SalVia splendens, together with an artifact (5), arising from salvisplendin D (4) by addition of diazomethane, and the
already known clerodane olearin (6). The structures of the new compounds (1-5) were established mainly by 1D and
2D NMR spectroscopic studies and, in the case of salvisplendin A (1), by chemical correlation with splenolide B (7).
Complete 1H and 13C NMR assignments for olearin (6), not published hitherto, are also reported.
The clerodane diterpenoid salvinorin A (1), the main active component of the psychotropic herb
Salvia divinorum, has been reported to be a potent agonist at the k-opioid receptor. Computer modeling
suggested that splendidin (2) from S. splendens, as well as related compounds, might possess similar
activities. In the present study, this hypothesis was tested by determination of the binding properties of a
series of structural congeners, compounds 2–8, at the m-, d-, and k-opioid receptors. However, none of
these compounds showed significant binding to any of the opioid-receptor subtypes, thus disproving the
above hypothesis.
The novel compounds 7 and 8 were obtained semi-synthetically by selective modification of
salvifarin (5), isolated from Salvia farinacea, upon epoxide-ring opening with AcOH in the presence of
indium(III) triflate. Also, the X-ray crystal structure of salvifaricin (6; Fig.), obtained from S. farinacea,
was determined for the first time and used, in combination with in-depth NMR experiments, to elucidate
the absolute configurations of the new products. Our experiments demonstrate that the relatively wellaccessible
diterpenoid 6 could be used as starting material for future studies into the structure–activity
relationship at the k-opioid receptor.
 
2007 - Isolation and Chemical Modification of Clerodane Diterpenoids from Salvia Species as Potential Agonists at the k-Opioid Receptor



The clerodane diterpenoid salvinorin A (1), the main active component of the psychotropic herb
Salvia divinorum, has been reported to be a potent agonist at the k-opioid receptor. Computer modeling
suggested that splendidin (2) from S. splendens, as well as related compounds, might possess similar
activities. In the present study, this hypothesis was tested by determination of the binding properties of a
series of structural congeners, compounds 2–8, at the m-, d-, and k-opioid receptors. However, none of
these compounds showed significant binding to any of the opioid-receptor subtypes, thus disproving the
above hypothesis.
The novel compounds 7 and 8 were obtained semi-synthetically by selective modification of
salvifarin (5), isolated from Salvia farinacea, upon epoxide-ring opening with AcOH in the presence of
indium(III) triflate. Also, the X-ray crystal structure of salvifaricin (6; Fig.), obtained from S. farinacea,
was determined for the first time and used, in combination with in-depth NMR experiments, to elucidate
the absolute configurations of the new products. Our experiments demonstrate that the relatively wellaccessible
diterpenoid 6 could be used as starting material for future studies into the structure–activity
relationship at the k-opioid receptor.
 
2012 - Polyphenolic profile and biological activity of Salvia splendens leaves

Abstract
Objectives The aim of this study was to investigate a new flavone triglycoside,
together with eleven phenolic metabolites from 80% aqueous methanol extract
of S. splendens leaves (AME) and assessment of its hypoglycemic and antiinflammatory
activities along with in vitro antioxidant effect.
Methods The phenolic composition of S. splendens leaves was analyzed using UV,
1D and 2DNMRand negative ESI-MS spectroscopy.Hypoglycemic activity of AME
was assessed by measuring blood glucose in streptozotocin induced-diabetic rats.
Antiinflammatory activity was evaluated using the carrageenan-induced paw
oedema test.Antioxidant activity was evaluated in vitro using DPPH test.
Key findings Twelve phenolic metabolites including three phenolic acids, namely
caffeic acid 1, rosmarinic acid 2 and methyl rosmarinate 3; four flavone glycosides
viz the new compound luteolin 7-O-(4",6"-di-O-a-L-rhamnopyranosyl)-b-Dglucopyranoside
4, apigenin 7-O-b-D-rutinoside 5, cosmosiin 6 and cinaroside 7,
together with four flavones aglycone, luteolin 8, apigenin 9, pedalitin 10 and crisiliol
11 in addition to one coumarin, 6,7-dihydroxycoumarin 12 were isolated from the
leaves of S. splendens Sellow ex Roem & Schult. The AME of S. splendens was non
toxic to mice up to 5 g/kg b.wt. it exhibited a significant hypoglycemic activity at 250
and 500 mg/kg as comparedwith control pre-drug (zero time) for each group aswell
as the diabetic control. Moreover, AME exhibited a significant antiinflammatory
activity only at 1000 mg/kg in comparison to indomethacin. Finally,AME exhibited
a marked significant scavenging activity against DPPH; the maximum reactive reaction
rate after 5 min was 62.9, 82.5, 83.7, 84.3 and 85.1% for the concentrations 10,
20, 30, 40 and 50 mg/ml, respectively in comparison to L-ascorbic acid (86.8%).
Conclusions This is the first study reporting the identification of a new flavone triglycoside,
alongwith eleven known phenolic metabolites fromAMEof S. splendens. It
showed significant hypoglycemic and antiinflammatory effects in dose dependant
manner.Moreover it showed an in vitro antioxidant activity.
 
2008 - Synthetic studies of neoclerodane diterpenoids from Salvia splendens and evaluation of opioid receptor affinity



Salvinorin A (1), a neoclerodane diterpene from the hallucinogenic mint Salvia divinorum, is the only
known non-nitrogenous and specific k-opioid agonist. Several structural congeners of 1 isolated from
Salvia splendens (2–8) together with a series of semisynthetic derivatives (9–24), some of which possess
a pyrazoline structural moiety (9, 19–22), have been tested for affinity at human m, d, and k opioid receptors.
None of these compounds showed high affinity binding to these receptors. However, 10 showed
modest affinity for k receptors suggesting that other natural neoclerodanes from different Salvia species
may possess opioid affinity.
 
2006 - Clerodane Diterpenoids from Salvia splendens.pdf
2006 - Complete 1H and 13C NMR assignments of clerodane diterpenoids of Salvia splendens.pdf
2007 - Isolation and Chemical Modification of Clerodane Diterpenoids from Salvia Species as Potential Agonists at the k-Opioid Receptor.pdf
2008 - Synthetic studies of neoclerodane diterpenoids from Salvia splendens and evaluation of opioid receptor affinity.pdf
2009 - Synthetic studies on neoclerodane diterpenes from Salvia splendens oxidative modifications of ring A.pdf
2012 - Polyphenolic profile and biological activity of Salvia splendens leaves.pdf
 
Top